Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2009 May 15;48(10):1475-8. doi: 10.1086/598334.

Effect of selenium supplements on hemoglobin concentration and morbidity among HIV-1-infected Tanzanian women.

Author information

1
Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA. rkupka@post.harvard.edu

Abstract

Selenium deficiency may increase risks of anemia and morbidity among people with human immunodeficiency virus infection. We therefore investigated the effect of selenium supplements (200 microg of selenomethionine) on these end points among 915 pregnant Tanzanian women. Hemoglobin concentration was measured at baseline (at 12-27 weeks of gestation) and at 6 weeks and 6 months postpartum, and morbidity data were collected during monthly visits to the clinic. Selenium supplements had no effect on hemoglobin concentrations during follow-up (mean difference, 0.05 g/dL; 95% confidence interval, -0.07 to 0.16 g/dL) but reduced diarrheal morbidity risk by 40% (relative risk, 0.60; 95% confidence interval, 0.42-0.84). There was no effect on the other morbidity end points.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT00197561.

PMID:
19368503
PMCID:
PMC2777617
DOI:
10.1086/598334
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems Icon for PubMed Central
    Loading ...
    Support Center